2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate(CAS: 143157-22-6)

This compound falls under the scope of the REACH regulation and may require registration with ECHA. It should be classified and labeled according to GHS guidelines, which may include hazards such as flammability and reactivity. The FDA and EPA may also have specific requirements for its handling and disposal based on its potential toxicity and environmental impact.

Alternative reagents such as 2-deoxy-2-fluoro-D-ribofuranose or 2-deoxy-D-ribofuranose can be used as substitutes in some synthetic pathways. Isomers or analogs like 2-deoxy-2,2-difluoro-L-ribofuranose might also be considered depending on the specific application and desired properties.

There is growing interest in this compound for its potential use as a building block in the synthesis of nucleoside analogs and antiviral drugs. Research trends are focusing on its application in drug discovery and development, particularly in the areas of antiretroviral and anticancer therapies. Market trends indicate increasing demand due to its unique chemical properties and potential in medicinal chemistry.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration can be a viable option, but must be conducted under controlled conditions to ensure complete destruction and minimize environmental impact. Environmental protection measures include proper containment to prevent leakage and spillage, and adherence to local and national regulations regarding hazardous waste management.